Skip to main content
Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
1.040
-0.010 (-0.95%)
At close: Jun 11, 2025, 4:00 PM
1.000
-0.040 (-3.85%)
Pre-market: Jun 12, 2025, 7:42 AM EDT

Revenue by Product

Fiscal year is September - August.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Aug '24 Aug '23 Aug '22 Aug '21 Aug '20 2017 - 2019
Intellectual Property Licensing
457.99K
Log In
Log In
Log In
Log In
Upgrade
Intellectual Property Licensing Growth
211.98%
Log In
Log In
Log In
Log In
Upgrade
Business-to-business Product
5.39K
Log In
Log In
Log In
Log In
Upgrade
Business-to-business Product Growth
-87.80%
Log In
Log In
Log In
Log In
Upgrade
Research & Development
900.00
Log In
Log In
Log In
Log In
Upgrade
Research & Development Growth
-97.45%
Log In
Log In
Log In
Log In
Upgrade
Corporate
-
Log In
Log In
Log In
Log In
Upgrade
Corporate Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is September - August.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Aug '24 Aug '23 Aug '22 Aug '21 Aug '20 2017 - 2019
United States and Canada
464.28K
Log In
Log In
Log In
Log In
Upgrade
United States and Canada Growth
105.24%
Log In
Log In
Log In
Log In
Upgrade